Prof. Jens Schwamborn - Co-founder of OrganoTherapeutics
Curriculum vitae of Prof. Jens Schwamborn
Prof. Jens Schwamborn is a professor at the University of Luxembourg and conducts research on Morbus using 3D brain organoids. Together with Javier Jarazo, he founded OrganoTherapeutics
Jens Schwamborn is a professor at the University of Luxembourg in the Department of Neuroscience. His expertise is in stem cell and Parkinson’s disease research. In the course of this research, he has founded OrganoTherapeutics and is developing three-dimensional brain organoids. These multiple award-winning “mini-brains” are being used in research to treat Parkinson’s in the near future not only symptomatically, but at its onset.
PROF. JENS SCHWAMBORN: CURRICULUM VITAE
Jens Schwamborn was born in Germany in 1977 and initially studied chemistry at the University of Essen and biochemistry at the University of Witten. He obtained his doctorate (Dr. rer. nat.) at the Westphalian Wilhelms University in Münster at the Institute of General Zoology and Genetics. After his PhD, Jens Schwamborn was employed as a postdoctoral researcher at the Westfälische Wilhelms-Universität Münster, the Institute of Neuroscience of the Academy of Sciences Shanghai and the Institute of Molecular Biotechnology of the Austrian Academy of Sciences in Vienna. From 2009 to 2013, he supervised his own projects as a junior research group leader at Westfälische Wilhelms-Universität in Münster. Since 2013, he has held a professorship in cell and developmental biology at the University of Luxembourg and also works as a project leader at the Luxembourg Centre for Systems Biomedicine (LCSB).
PROF. JENS SCHWAMBORN: ENTREPRENEURIAL ACTIVITIES
In 2016, Prof. Jens Schwamborn founded Brainingineering Technologies SARL together with colleagues. In 2019, he co-founded OrganoTherapeutics SARL-S with Dr. Javier Jarazo, and has since served as its CEO. In 2020, he joined the Houston cohort of the MassChallenge Accelerator Program and the Creative Destruction Lab (CDL) in Oxford. OrganoTherapeutics is engaged in research on mini-brains grown in vitro from stem cells of people with Parkinson’s to develop new drugs that can intervene at the onset of Parkinson’s.
PROF. JENS SCHWAMBORN: CURRENT RESEARCH
With OrganoTherapeutics, Prof. Jens Schwamborn is also currently involved in research on the corona virus SARS-CoV2. There is increasing evidence that SARS-CoV2 not only attacks the respiratory tract, but also causes neurological damage. The 3D brain organoids developed by OrganoTherapeutics may therefore prove to be an authoritative tool for developing new agents that specifically target the neurological effects of SARS-CoV2 infection. For this project, OrganoTherapeutics is collaborating with the Luxembourg Institute of Health (LIH) and DeepBioInsights.
PROF. JENS SCHWAMBORN: PRIZES AND AWARDS
In 2021, OrganoTherapeutics received the SLAS New Product Award for the development of their “mini-brains”. OrganoTherapeutics and Prof. Jens Schwamborn received further prizes and awards with a distinction in the ience4Life Venture Cup in the “Concept Phase” category (2020) and the Luxembourg Health Care Award for “Start-up of the Year” (2017).